TAILOR BIO

Live / Registered — Registered (as of 27 May 2025)

What this means for you

Registered since 27 May 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98549945
Registration number
7806673
Mark type
Stylized text
Filed
14 May 2024
Published for opposition
08 Apr 2025
Registered
27 May 2025
Attorney of record
Richard S. Finkelstein

Goods and services

  • Class 001 — Chemicals: Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, except for medical or veterinary use; Kits containing chemical reagents and a protocol for use thereof for non-medical purposes; Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics; Kits comprising nucleotides, reagents, enzyme substrates, buffers, chemical preparations, or biological preparations for scientific and research use including in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, and biotechnology.
  • Class 005 — Pharmaceuticals: Pharmaceuticals, namely, for the treatment of cancers; Pharmaceutical drugs, namely, for the treatment of cancers; Pharmaceutical preparations for the treatment of cancers; Pharmaceutical preparations for the treatment of cancers with chromosomal abnormalities; Pharmaceutical preparations for the treatment of cancers with chromosomal instabilities; Pharmaceutical preparations acting on cancers; Pharmaceutical preparations acting on cancers with chromosomal abnormalities; Pharmaceutical preparations acting on cancers with chromosomal instabilities; Medicine, namely, for the treatment of cancers; Medicines for human purposes, namely, for the treatment of cancers; Medicine for the treatment of cancers with chromosomal abnormalities; Medicine for the treatment of cancers with chromosomal instabilities; Chemicals for pharmaceutical use, namely, for the treatment of cancers; Chemical reagents for medical use; Chemical preparations for medical purposes, namely, for the treatment of cancers; Drugs for medical purposes, namely, for the treatment of cancers, Diagnostic reagents and preparations for medical or veterinary use, Kits containing chemical reagents and a protocol for use thereof for medical purposes
  • Class 009 — Scientific and electric apparatus: Downloadable software for data analysis of the genome for chromosomal instabilities; Downloadable application software for data analysis of the genome for chromosomal instabilities; Downloadable computer software for data analysis of the genome for chromosomal instabilities; Downloadable bioinformatics software for data analysis of the genome for chromosomal instabilities; Downloadable computer software platforms for data analysis of the genome for chromosomal instabilities; Downloadable artificial intelligence software for data analysis of the genome for chromosomal instabilities; Downloadable artificial intelligence software platforms for data analysis of the genome for chromosomal instabilities; Downloadable artificial intelligence software for searching, tracking, exploration, and analysis of data for use in the field of healthcare; Downloadable artificial intelligence software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines for cancers with chromosomal abnormalities; Computer hardware and downloadable software for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; Scientific apparatus and instruments, namely, spectrometers, centrifuges, and microscopes for use in laboratory research; Scientific specimens for laboratory use, namely, prepared microscope slides and sample vials containing chemical reagents
  • Class 035 — Advertising and business services: Database management; Database management and reporting services for business purposes; Business information services; Business consulting services; Business consulting services in the field of drug discovery; Business consulting services in the field of biomarker discovery; Business consulting services in the field of genomics; Business consulting in the field of chromosomal abnormalities; Market intelligence services; Data processing; Data processing in the field of drug discovery; Data processing in the field of medical diagnosis; Data processing in the field of biomarker discovery; Data processing in the field of genomics; Data processing in the field of bioinformatics; Data processing in the field of chromosomal abnormalities; Data processing in the field of chromosomal instabilities; Information, advisory and consultancy services in relation to all of the aforesaid
  • Class 041 — Education and entertainment services: Publication of books; Publication of journals; Publication of electronic books and journals online; Publication of material, namely, teaching materials that can be accessed from databases or from the Internet; Publication of scientific research findings; Publication of electronic books and journals featuring the results of clinical trials; Publication of electronic books and journals featuring the results of clinical trials for pharmaceutical preparations
  • Class 042 — Scientific and technological services: Compilation of data for use in scientific research; Data analysis in the field of genomics; Data analysis in the field of biomarker discovery; Scientific and technological services, namely, research in the fields of bioinformatics and drug discovery; Design and development of computer software; Providing online non-downloadable computer software for analyzing genomic and healthcare data; Platform as a Service [PaaS] featuring computer software platforms for data exploration and analysis in the field of healthcare; Platform as a Service [PaaS] featuring computer software platforms for data analysis in the research and development of pharmaceutical preparations; Software as a Service [SaaS] featuring computer software for data exploration in the field of healthcare; Software as a Service [SaaS] featuring artificial intelligence computer software for analyzing chromosomal abnormalities and instabilities; Medical and scientific research in the field of drug target discovery for development of pan-cancer precision therapies; Genetic engineering services, namely, scientific research in the field of genetic engineering; Scientific research in the field of genetics and drug discovery; Scientific research conducted using databases and the Internet in the field of genetics; Pharmaceutical research and development services; Drug discovery services; Scientific research and development; Consulting services in the fields of pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
  • Class 044 — Medical, beauty and agricultural services: Healthcare services; Healthcare information, advisory and consultancy services for cancers with chromosomal abnormalities; Healthcare information, advisory and consultancy services for cancers with chromosomal instabilities; Medical services; Medical information, advisory and consultancy services for cancers with chromosomal abnormalities; Medical testing for diagnostic or treatment purposes; Pharmaceutical services, namely, pharmaceutical compounding services; Pharmaceutical information relating to diagnostic properties of pharmaceuticals; Pharmaceutical advisory and consultancy services for cancers with chromosomal abnormalities; Pharmaceutical services, namely, pharmaceutical advice; Pharmaceutical information relating to, advisory and consultancy services for cancers with chromosomal instabilities; Advisory and collation of medical information in the healthcare sector in the field of pharmaceuticals; Providing medical information in the healthcare sector; Providing medical information concerning pharmaceuticals and the research and development of pharmaceuticals for cancers with chromosomal abnormalities; Advisory and collation of information in the healthcare sector; Providing medical information concerning pharmaceuticals and the research and development of pharmaceuticals for cancers with chromosomal instabilities; Health consultancy; Medical treatment services; Provision of personalised medicine information in the field of rare diseases; Medical advisory services relating to rare diseases; Advisory services relating to treatment of rare diseases; Medical health assessment services; Advisory services relating to medical instruments, namely, providing guidance on the selection and use of medical diagnostic instruments for healthcare professionals; Therapy services, namely, gene therapy services; Medical and health care services relating to DNA, genetics and genetic testing; Genetic testing for medical purposes; Providing cancers screening services

Owner

Prosecution history

  • 27 May 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 27 May 2025 — REGISTERED-PRINCIPAL REGISTER
  • 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 08 Apr 2025 — PUBLISHED FOR OPPOSITION
  • 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 13 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 13 Mar 2025 — EXAMINER'S AMENDMENT ENTERED
  • 13 Mar 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 13 Mar 2025 — EXAMINERS AMENDMENT E-MAILED
  • 13 Mar 2025 — EXAMINERS AMENDMENT -WRITTEN
  • 24 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 24 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 24 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 09 Dec 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 09 Dec 2024 — NON-FINAL ACTION E-MAILED

View this trademark record on Marksy